These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28660989)

  • 21. Cinacalcet to prevent parathyrotoxic crises in hypercalcaemic patients awaiting parathyroidectomy.
    Rostoker G; Bellamy J; Janklewicz P
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
    Silverberg SJ; Rubin MR; Faiman C; Peacock M; Shoback DM; Smallridge RC; Schwanauer LE; Olson KA; Klassen P; Bilezikian JP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3803-8. PubMed ID: 17666472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Cinacalcet in Kidney Transplant Patients With Hyperparathyroidism.
    Jo HA; Han KH; So YK; Jun H; Han SY
    Transplant Proc; 2019 Jun; 51(5):1397-1401. PubMed ID: 31155177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.
    Cetani F; Saponaro F; Banti C; Cianferotti L; Vignali E; Chiavistelli S; Viccica G; Pinchera A; Marcocci C
    J Endocrinol Invest; 2012 Jul; 35(7):655-60. PubMed ID: 21971564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
    Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience.
    Manaka K; Sato J; Kinoshita Y; Ito N; Fujita M; Iiri T; Nangaku M; Makita N
    Endocr J; 2019 Aug; 66(8):683-689. PubMed ID: 31092749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation.
    Pinho LR; Ribeiro Santos MJ; Pestana Vasconcelos M
    Clin Nephrol; 2011 Mar; 75(3):263-8. PubMed ID: 21329638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cinacalcet for the treatment of primary hyperparathyroidism.
    Dillon ML; Frazee LA
    Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism.
    Faggiano A; Di Somma C; Ramundo V; Severino R; Vuolo L; Coppola A; Panico F; Savastano S; Lombardi G; Colao A; Gasperi M
    Endocrine; 2011 Jun; 39(3):283-7. PubMed ID: 21445714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary hyperparathyroidism.
    Muñoz-Torres M; García-Martín A
    Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of recurrent renal stones with Cinacalcet in a patient with primary hyperparathyroidism.
    Chauhan P; Gittoes NJ; Geberhiwot T
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27520998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors.
    Mingione A; Verdelli C; Terranegra A; Soldati L; Corbetta S
    Curr Cancer Drug Targets; 2015; 15(7):563-74. PubMed ID: 26033088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism.
    Timmons JG; Manners R; Bailey M; McDougall C
    Hormones (Athens); 2021 Sep; 20(3):587-589. PubMed ID: 33881757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study.
    Frey S; Goronflot T; Blanchard C; Kerleau C; Gourraud PA; Wargny M; Caillard C; Hourmant M; Figueres L; Mirallié É;
    Langenbecks Arch Surg; 2022 Sep; 407(6):2489-2498. PubMed ID: 35596781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation.
    Brunelli SM; Dluzniewski PJ; Cooper K; Do TP; Sibbel S; Bradbury BD
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1058-67. PubMed ID: 26238994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of a 3-Year Therapy With Cinacalcet in Persistent Hyperparathyroidism After Renal Transplant.
    Rivelli GG; Lopes de Lima M; Mazzali M
    Transplant Proc; 2020 Jun; 52(5):1284-1286. PubMed ID: 32204903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands.
    Picazo Sánchez M; Cuxart Pérez M; Sans Lorman R; Sardà Borroy C
    Nefrologia; 2011; 31(1):126-7. PubMed ID: 21270934
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics.
    Foppiani L; Bottoni G; Piccardo A
    Acta Medica (Hradec Kralove); 2019; 62(4):156-160. PubMed ID: 32036848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.